US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

122.85

+1.481.22%

Post-market: 123.030.1800+0.15%19:56 EST

Volume:8.95M

Turnover:1.10B

Market Cap:8.14B

PE:6.74

High:123.47

Open:121.55

Low:120.96

Close:121.37

52wk High:123.47

52wk Low:66.66

Shares:66.30M

Float Shares:62.93M

Volume Ratio:0.79

T/O Rate:14.22%

Dividend:0.04

Dividend Rate:0.03%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sunway Gets Downgrade on Limited Upside -- Market Talk

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Teva Pharmaceutical (TEVA)

What United Parcel Service (UPS)'s Healthcare Pivot and Safety Probe Mean for Shareholders

Simply Wall St.

Fangzhou and Tencent Healthcare Launch Full-Stack AI Solution for Chronic-Disease Management

Fisher & Paykel Healthcare (NZSE:FPH) Net Margin Doubles to 20.2%, Supports Profitability Narrative

Simply Wall St.

Parkway Life REIT Could Capture Singapore Healthcare's Growth -- Market Talk

Analysts Offer Insights on Healthcare Companies: Nyxoah (NYXH) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)

IHH Healthcare's Growth Momentum Likely to Be Sustained Into 2026 -- Market Talk

Ryman Healthcare Achieves Positive Cash Flow Amidst Strategic Transformation

Staar Surgical, Gold Royalty See Activist Action -- Barrons.com

Sector Update: Health Care Stocks Mixed in Afternoon Trading

MT Newswires Live

US Market's Undiscovered Gems With Promising Potential

Simply Wall St.

IO Biotech Announces Participation in Upcoming December Investor Conferences

Analysts Conflicted on These Healthcare Names: Terns Pharmaceuticals (TERN) and Ironwood Pharma (IRWD)

Healthcare ETFs Trounce Tech, Grab Billions As Big Money Flees Bubble Fears

Benzinga_recent_news

Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference

Analysts’ Opinions Are Mixed on These Healthcare Stocks: AbbVie (ABBV) and Clinigence Holdings (NUTX)

Repligen Corporation to Present at Evercore Healthcare Conference

Sarepta Therapeutics (SRPT) Gets a Buy from Wells Fargo

Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/XBI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":122.85,"timestamp":1764190800000,"preClose":121.37,"halted":0,"volume":8946559,"hourTrading":{"tag":"盘后","latestPrice":123.03,"preClose":122.85,"latestTime":"19:56 EST","volume":102305,"amount":12563957.4929,"timestamp":1764205013938},"delay":0,"floatShares":62925000,"shares":66300000,"eps":18.23,"marketStatus":"Closed Thanksgiving Day","change":1.48,"latestTime":"11-26 16:00:00 EST","open":121.55,"high":123.47,"low":120.955,"amount":1096379602.10517,"amplitude":0.020722,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1764320400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":121.37,"sharesOutstanding":66300000,"nav":121.371028,"aum":8046899163.46,"dividendRate":0.000342,"bidAskSpread":0.000143,"preHourTrading":{"tag":"盘前","latestPrice":121.49,"preClose":121.37,"latestTime":"09:29 EST","volume":5094,"amount":619134.0514560001,"timestamp":1764167399999},"postHourTrading":{"tag":"盘后","latestPrice":123.03,"preClose":122.85,"latestTime":"19:56 EST","volume":102305,"amount":12563957.4929,"timestamp":1764205013938},"volumeRatio":0.7942239994565753,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1771563600000,"strike":"100.0","timestamp":1764177771261,"price":1.5,"volume":15000,"amount":2250000,"type":"+"},{"symbol":"XBI","call":false,"expireDate":1771563600000,"strike":"115.0","timestamp":1764177771261,"price":4.75,"volume":15000,"amount":7125000,"type":"+"}]},"impliedVol":0.3024,"impliedVolPercentile":0.548},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":62925000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7942239994565753,"shares":66300000,"dividePrice":0.042,"high":123.47,"amplitude":0.020722,"preClose":121.37,"low":120.955,"week52Low":66.66,"pbRate":"--","week52High":123.47,"institutionHeld":0.8511,"latestPrice":122.85,"eps":18.23,"divideRate":0.000342,"volume":8946559,"delay":0,"ttmEps":18.23,"open":121.55,"prevYearClose":90.06,"prevWeekClose":116.65,"prevMonthClose":112.71,"prevQuarterClose":100.2,"fiveDayClose":114.5,"twentyDayClose":110.96,"sixtyDayClose":93.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"},{"date":"2024-12-23","symbol":"XBI","amount":0.002687,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-26"},{"date":"2024-09-23","symbol":"XBI","amount":0.015228,"announcedDate":"2024-09-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-23","defaultRemindTime":1727098200000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-25","payableDate":"2024-09-23","currency":"USD","dateTimestamp":1727064000000,"payDate":"2024-09-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2015-12-18","recordDate":"2015-12-22","paymentDate":"2015-12-29","value":0.148677,"currency":"USD"},{"executeDate":"2016-03-18","recordDate":"2016-03-22","paymentDate":"2016-03-29","value":0.057833,"currency":"USD"},{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-27","value":0.045491,"currency":"USD"},{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2586224806","title":"Sunway Gets Downgrade on Limited Upside -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2586224806","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586224806?lang=en_us&edition=fundamental","pubTime":"2025-11-27 16:45","pubTimestamp":1764233100,"startTime":"0","endTime":"0","summary":"0845 GMT - Sunway's stock has limited upside, with the upcoming listing of Sunway Healthcare Group in 1Q next year likely to widen the holding-company's discount, CGS International says in a note. Analyst Chong Tjen-San says that Sunway is unlikely to have substantial businesses beyond property development post-listing, downgrading the stock to hold from add, with an unchanged target price of MYR5.90. The analysts also trims Sunway's 2025-2027 EPS forecasts by 5%, 1% and 1%, respectively, to reflect lower bed-capacity assumptions for Sunway Healthcare, alongside more moderate margins. Shares are 2.7% lower at MYR5.40. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LABU","BK4588","BK4585","XBI","XLV"],"gpt_icon":0},{"id":"2586481072","title":"Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Teva Pharmaceutical (TEVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2586481072","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586481072?lang=en_us&edition=fundamental","pubTime":"2025-11-27 16:20","pubTimestamp":1764231609,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Neurocrine (NBIX – Research Report) and Teva Pharmac...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurocrine-nbix-and-teva-pharmaceutical-teva-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurocrine-nbix-and-teva-pharmaceutical-teva-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEVA","BK4581","LU0109394709.USD","BK4585","LU0154245673.USD","XLV","LU2324357040.USD","BK4137","BK4007","LU1983299246.USD","XBI","BK4584","HCSG","NBIX","BK4566","LU2065171402.SGD","LU0889565916.HKD","LU0823416689.USD","LU2065171311.SGD","LU2065169927.USD","BK4596","BK4557","BK4139","LABU","LU0154245756.USD","LU2065170008.USD","LU0029874061.USD","LU0320765992.SGD","BK4559","LU0128526141.USD","BK4588"],"gpt_icon":0},{"id":"2586248712","title":"What United Parcel Service (UPS)'s Healthcare Pivot and Safety Probe Mean for Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2586248712","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586248712?lang=en_us&edition=fundamental","pubTime":"2025-11-27 15:27","pubTimestamp":1764228473,"startTime":"0","endTime":"0","summary":"United Parcel Service (UPS) recently completed its acquisition of Andlauer Healthcare and has undertaken significant operational shifts, including grounding its MD-11 fleet following a fatal crash and announcing a 5.9% rate increase effective December 22.\nAmid these changes, UPS is undergoing a substantial transformation by reducing its reliance on Amazon, executing large-scale cost-cutting initiatives, and investing in higher-margin healthcare logistics, while being subject to a regulatory...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/238570-main-header/1756254356401","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/238570-main-header/1756254356401"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/transportation/nyse-ups/united-parcel-service/news/what-united-parcel-service-upss-healthcare-pivot-and-safety","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/transportation/nyse-ups/united-parcel-service/news/what-united-parcel-service-upss-healthcare-pivot-and-safety","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0965509283.SGD","LU1066053197.SGD","LU1868836914.USD","XLV","LU2237957902.USD","BK4548","IE00B5TLWC47.USD","LU2463028550.USD","LU1868837300.USD","LU2456880835.USD","LU1674673428.USD","LU0965509010.AUD","LU1674673691.USD","LU0787776722.HKD","LU0211327993.USD","LU2237957811.SGD","LU2028103732.USD","IE00BMPRXN33.USD","IE00B775SV38.USD","USAW.SI","IE000ITXATA3.USD","LU0354030438.USD","LU2063271972.USD","LU0265550359.USD","LU0345768153.USD","LABU","LU0642271901.SGD","LU0689472784.USD","LU0130103400.USD","LU2360106780.USD","BK4535","LU2420271590.USD","LU2089283258.USD","XBI","LU1496350171.SGD","UPS","IE0009G5SDU7.USD","HCSG","SG9999014906.USD","BK4538","IE00BKPKM429.USD","LU0672654240.SGD","LU1280957306.USD","IE00BWXC8680.SGD","LU2065169927.USD","LU0882574139.USD","LU0823421416.USD","LU0823421333.USD","IE000YTNTUN2.SGD"],"gpt_icon":1},{"id":"2586221231","title":"Fangzhou and Tencent Healthcare Launch Full-Stack AI Solution for Chronic-Disease Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2586221231","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586221231?lang=en_us&edition=fundamental","pubTime":"2025-11-27 15:00","pubTimestamp":1764226800,"startTime":"0","endTime":"0","summary":"SHANGHAI, Nov.  27, 2025  (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, and Tencent Healthcare jointly l","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/27/3195482/0/en/Fangzhou-and-Tencent-Healthcare-Launch-Full-Stack-AI-Solution-for-Chronic-Disease-Management.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1615","LU0128522744.USD","LU1242518857.USD","LU0320764243.SGD","BK4023","LU0329678170.USD","LU0463099449.HKD","SGXZ81514606.USD","LU0862451753.SGD","GB00BDT5M118.USD","00700","BK1531","LU0011963245.USD","LU0531970944.HKD","LU1719994722.HKD","LU2051468812.USD","SG9999014674.SGD","IE00B0169N27.USD","IE0003895053.USD","SG9999001069.SGD","LU1282649810.SGD","LU0163747925.USD","LU1770034418.SGD","TCHmain","LU2251237306.USD","XBI","IE00B8HQ1Z84.USD","LU0650527681.SGD","HTCD.SI","LU0348827113.USD","LU2251237488.HKD","LU0605514214.HKD","LU0251144936.SGD","LU1226288097.SGD","SG9999001846.SGD","LU1196710195.USD","AI","LU0107464264.USD","LU0211977185.USD","LU0972618739.USD","LU3063872942.SGD","LU0633140560.USD","HCSG","LU1048596156.SGD","LABU","LU0210527791.USD","LU0329678337.USD","LU0572940350.SGD","LU2045819591.USD","XLV"],"gpt_icon":1},{"id":"2586248780","title":"Fisher & Paykel Healthcare (NZSE:FPH) Net Margin Doubles to 20.2%, Supports Profitability Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2586248780","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586248780?lang=en_us&edition=fundamental","pubTime":"2025-11-27 13:33","pubTimestamp":1764221591,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare (NZSE:FPH) just posted its H1 2026 results with revenue of NZ$1.1 billion and net income of NZ$213 million, as well as basic EPS of NZ$0.36. Over the last year, the company has seen total revenue rise from NZ$951.2 million in H1 2025 to the latest NZ$1.1 billion. Net income has climbed from NZ$153.2 million to NZ$213 million. Margins have notably expanded this period, signalling a clear improvement in profitability for investors to consider.\nSee our full analysis...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/875015-main-header/1585186825715","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/875015-main-header/1585186825715"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/nz/healthcare/nzx-fph/fisher-paykel-healthcare-shares/news/fisher-paykel-healthcare-nzsefph-net-margin-doubles-to-202-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/nz/healthcare/nzx-fph/fisher-paykel-healthcare-shares/news/fisher-paykel-healthcare-nzsefph-net-margin-doubles-to-202-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4581","BK8004","BK4585","LABU","XLV","FPH","XBI","FPH.NZ","BK4588","BK4193"],"gpt_icon":0},{"id":"2586218240","title":"Parkway Life REIT Could Capture Singapore Healthcare's Growth -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2586218240","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586218240?lang=en_us&edition=fundamental","pubTime":"2025-11-27 11:23","pubTimestamp":1764213780,"startTime":"0","endTime":"0","summary":"0323 GMT - Parkway Life Real Estate Investment Trust is likely able to capture the Singapore healthcare industry's double-digit growth through variable rent, says UOB Kay Hian's Jonathan Koh in a note. Singapore hospital revenue of the REIT's sponsor, IHH Healthcare, has grown since 2023 and is likely to rebound on a half-on-half basis in 2H this year, the analyst says. This could help support rent at hospitals which are part of Parkway Life's portfolio, he notes. The REIT is considering asset enhancements at one of its hospitals, which could add incremental space, he says. The Singapore-listed REIT could also buy more assets in the city-state to fuel growth. UOB KH raises its target price to S$5.42 from S$5.34 and maintains a buy rating. Units are steady at S$4.02. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999000475.SGD","XLV","SG9999001135.SGD","LU0577902611.USD","BK4581","LU0516423091.SGD","LU0955669360.SGD","SG9999004220.SGD","LU0588545904.SGD","LU2264538146.SGD","LU0264606111.USD","LU0979878070.USD","LU0048597586.USD","LU0315178854.USD","SG9999005177.SGD","SG9999014484.SGD","LU0918141887.USD","LU0577902538.SGD","LU0210637038.USD","C2PU.SI","SG9999002620.SGD","SG9999000343.SGD","LU0738912210.USD","LABU","LU0261945553.USD","PRKWF","LU1988902786.USD","LU2506952097.USD","BK6516","XBI","SG9999008742.SGD","LU0737861269.HKD","SG9999002604.SGD","SG9999003826.SGD","SGXZ27511609.SGD","REIT","CFA.SI","LU0878005551.USD","LU2506951875.HKD","HCSG","LU0588545730.USD","LU2506952170.USD","LU0577902371.SGD","LU0873338254.USD","BK4585","LU0532188223.SGD","LU2506951958.HKD","LU0588545490.SGD","8C8U.SI"],"gpt_icon":1},{"id":"2586221292","title":"Analysts Offer Insights on Healthcare Companies: Nyxoah (NYXH) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2586221292","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586221292?lang=en_us&edition=fundamental","pubTime":"2025-11-27 09:40","pubTimestamp":1764207604,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nyxoah (NYXH – Research Report) and Fisher & Payke...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nyxoah-nyxh-and-fisher-paykel-healthcare-corporation-limited-otherfspkf-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nyxoah-nyxh-and-fisher-paykel-healthcare-corporation-limited-otherfspkf-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","BK4082","FPH.NZ","BK4585","BK4581","BK8004","BK4588","NYXH","XLV"],"gpt_icon":0},{"id":"2586294602","title":"IHH Healthcare's Growth Momentum Likely to Be Sustained Into 2026 -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2586294602","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586294602?lang=en_us&edition=fundamental","pubTime":"2025-11-27 09:04","pubTimestamp":1764205440,"startTime":"0","endTime":"0","summary":"0104 GMT - IHH Healthcare's earnings momentum is expected to hold into 2026, Maybank IB analysts Nur Natasha Ariza and Yin Shao Yang say in a note. The outlook is supported by improving fundamentals in Turkey and Europe, patient recovery and operational efficiencies in India, steady demand and rising medical tourism in Malaysia, and utilization ramp-up in Singapore following the Mt. Elizabeth Orchard renovations. They raise IHH's 2025-2027 core net profit estimates by 5%, 1% and 2%, respectively, to factor in stronger revenue in Singapore and India. Maybank raises IHH's target price to MYR9.48 from MYR9.42 while maintaining a buy rating on the stock. Shares are unchanged at MYR8.07. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK6092","BK4137","BK4588","HCSG","LU0128526141.USD","Q0F.SI","XLV","BK4585","LABU","BK6511","LU0029874061.USD","XBI","MNDmain"],"gpt_icon":0},{"id":"2586260618","title":"Ryman Healthcare Achieves Positive Cash Flow Amidst Strategic Transformation","url":"https://stock-news.laohu8.com/highlight/detail?id=2586260618","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586260618?lang=en_us&edition=fundamental","pubTime":"2025-11-27 04:48","pubTimestamp":1764190088,"startTime":"0","endTime":"0","summary":"An update from Ryman Healthcare ( ($RHCGF) ) is now available. Ryman Healthcare has reported its first positive free cash flow in a decade, marking...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ryman-healthcare-achieves-positive-cash-flow-amidst-strategic-transformation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ryman-healthcare-achieves-positive-cash-flow-amidst-strategic-transformation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4588","BK4585","BK4581","LABU","RYM.NZ","BK8050","XBI"],"gpt_icon":0},{"id":"2586424267","title":"Staar Surgical, Gold Royalty See Activist Action -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2586424267","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586424267?lang=en_us&edition=fundamental","pubTime":"2025-11-27 04:34","pubTimestamp":1764189240,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Nov. 20 through Nov. 26, 2025. Source: VerityData. Tether Holdings raised its stake in the gold-focused royalty company to 20,170,713 shares. Tether Holdings did so through the purchase of 11,870,713 Gold Royalty shares from Oct. 17 through Nov. 18 at per share prices ranging from $3.49 to $3.74. Following the latest purchases, Tether Holdings owns an 11.6% stake in Gold Royalty's outstanding stock. Shares of Gold Royalty have gained 208.9% in value in 2025.Adimab lowered its stake in the biopharmaceutical company to 20,454,490 shares. Adimab did so through the open market sale of 1,233,416 Invivyd shares on Nov. 17 at per share prices rang","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","SGCmain","1OZmain","XLV","DUST","NESR","USDT.USD.HKCC","ACHC","GDX","USDT.USD.CC","BK4179","BK4198","BK4139","NUGT","LABU","BK4539","BK4082","IVVD","SGUmain","GCmain","518880","STAA","BFLY","BK4588","MGCmain","BK4548","BK4585","BK4185","GROY","BK4017","BK4581","159934","IAU"],"gpt_icon":1},{"id":"2586426280","title":"Sector Update: Health Care Stocks Mixed in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2586426280","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586426280?lang=en_us&edition=fundamental","pubTime":"2025-11-27 02:51","pubTimestamp":1764183062,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed Wednesday afternoon, with the NYSE Health Care Index up 0.1% and the Health Care Select Sector SPDR Fund  decreasing 0.1%.The iShares Biotechnology ETF  added 0.7%.In corporate news, GE HealthCare  shares rose 0.3% after the firm said it has received premarket authorization from the US Food and Drug Administration for Pristina Recon DL, a 3D mammography image reconstruction technology.Novo Nordisk  shares gained 3.4%. The pharma giant said it has submitted a supplemental new drug application to the US Food and Drug Administration for a higher dose semaglutide injection of 7.2 milligrams to be used in combination with a reduced calorie diet and increased physical activity for chronic weight management in adults with obesity.Microbot Medical  shares jumped 14% after it said Wednesday that Emory University Hospital in Atlanta has become the first hospital to adopt its Liberty Endovascular Robotic System for patient care.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO","LABU","XLV","BK4082","XBI","GEHC","BK4585","BK4007","IE00BKVL7J92.USD","NVO.AU","BK4588","BK4532","LU1093756325.SGD","IBB","BK4599","LU0154236417.USD","LU0124676726.USD","BK4581","MBOT","LU1093756168.USD","BK7104","IE00BZ1G4Q59.USD","LU0689626769.HKD"],"gpt_icon":1},{"id":"2586261715","title":"US Market's Undiscovered Gems With Promising Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2586261715","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586261715?lang=en_us&edition=fundamental","pubTime":"2025-11-27 01:03","pubTimestamp":1764176619,"startTime":"0","endTime":"0","summary":"As major U.S. stock indices, including the Dow Jones, Nasdaq, and S&P 500, continue to experience gains entering the Thanksgiving holiday week, investors are keenly observing market dynamics that could impact small-cap stocks. With economic indicators showing mixed signals and broader market sentiment fluctuating, identifying promising yet lesser-known stocks becomes crucial for those looking to capitalize on potential opportunities in a dynamic environment.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/7013000-choice2-main-header/1585186648241","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7013000-choice2-main-header/1585186648241"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/banks/nasdaq-nbn/northeast-bank/news/us-markets-undiscovered-gems-with-promising-potential","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/banks/nasdaq-nbn/northeast-bank/news/us-markets-undiscovered-gems-with-promising-potential","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7101","BK4588","XLV","BK4182","BK4581","BK4211","PSI","XBI","NBN","PSIX","BK4196","LABU","BK4585","VMD","PSI.AU"],"gpt_icon":0},{"id":"2586266131","title":"IO Biotech Announces Participation in Upcoming December Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2586266131","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586266131?lang=en_us&edition=fundamental","pubTime":"2025-11-26 23:46","pubTimestamp":1764171960,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov.  26, 2025  (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, toda","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/26/3195234/0/en/IO-Biotech-Announces-Participation-in-Upcoming-December-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LABU","BK4139","BK4588","BK4585","XBI","XLV","IOBT"],"gpt_icon":0},{"id":"2586265617","title":"Analysts Conflicted on These Healthcare Names: Terns Pharmaceuticals (TERN) and Ironwood Pharma (IRWD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2586265617","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586265617?lang=en_us&edition=fundamental","pubTime":"2025-11-26 23:10","pubTimestamp":1764169806,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Terns Pharmaceuticals (TERN – Research Report) and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-terns-pharmaceuticals-tern-and-ironwood-pharma-irwd-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-terns-pharmaceuticals-tern-and-ironwood-pharma-irwd-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","LU0029874061.USD","HCSG","XBI","BK4137","LU0128526141.USD","TERN","BK4007","XLV","BK4139","IRWD","BK4585","BK4581"],"gpt_icon":0},{"id":"2586635772","title":"Healthcare ETFs Trounce Tech, Grab Billions As Big Money Flees Bubble Fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2586635772","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586635772?lang=en_us&edition=fundamental","pubTime":"2025-11-26 22:25","pubTimestamp":1764167100,"startTime":"0","endTime":"0","summary":"Healthcare ETFs are raking in fresh inflows while tech bleeds, reflecting a defensive shift as investors grow wary of frothy valuations.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/26/Budget-Bill-Sparks-National-Controversy.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/26/Budget-Bill-Sparks-National-Controversy.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/etfs/sector-etfs/25/11/49083042/healthcare-etfs-trounce-tech-grab-billions-as-big-money-flees-bubble-fears","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/etfs/sector-etfs/25/11/49083042/healthcare-etfs-trounce-tech-grab-billions-as-big-money-flees-bubble-fears","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["ABBV","XBI","LU0823416689.USD","BK4543","LU0323591593.USD","LU1585245621.USD","IE00BVYPNV92.GBP","LU1917777945.USD","IE00B2B36J28.USD",".IXIC","IE00BLSP4239.USD","BK4022","LU1551013342.USD","LU2237443978.SGD","BK4139","AI","LU1003077747.HKD","QQQ","JNJ","XLV","IE00B7SZLL34.SGD","LU1037948897.HKD","LU0708995401.HKD","LU0158827948.USD","LU1032466523.USD","BK4532","LU0786609619.USD","SG9999001176.SGD","LU1934455863.HKD","LU2089284900.SGD","LU1366192091.USD","LU1242518857.USD","IE00B3T34201.USD","LU2750360997.AUD","LU1037948541.HKD","LU1934455194.USD","LU1934455277.USD","LABU","LU1057294990.SGD","LU2552382215.SGD","LU0097036916.USD","LU0061475181.USD","LU2552382132.HKD","SGXZ81514606.USD","LU0310800379.SGD","HCSG","LU0672654240.SGD","FDN","LLY"],"gpt_icon":1},{"id":"2586252292","title":"Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2586252292","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586252292?lang=en_us&edition=fundamental","pubTime":"2025-11-26 21:00","pubTimestamp":1764162000,"startTime":"0","endTime":"0","summary":"WESTLAKE VILLAGE, Calif., Nov.  26, 2025  (GLOBE NEWSWIRE) -- Genelux Corporation  (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/26/3195094/0/en/Genelux-Corporation-to-Participate-in-a-Fireside-Chat-at-Piper-Sandler-37th-Annual-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4137","BK4588","GNLX","HCSG","LU0128526141.USD","XLV","BK4585","BK4139","LABU","LU0029874061.USD","XBI"],"gpt_icon":0},{"id":"2586252485","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: AbbVie (ABBV) and Clinigence Holdings (NUTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2586252485","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586252485?lang=en_us&edition=fundamental","pubTime":"2025-11-26 20:50","pubTimestamp":1764161411,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on AbbVie (ABBV – Research Report) and Clinigence Holdings (NUTX – R...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-abbvie-abbv-and-clinigence-holdings-nutx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-abbvie-abbv-and-clinigence-holdings-nutx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0965509283.SGD","IE0009355771.USD","LU0310799852.SGD","SG9999015986.USD","XLV","LU0203347892.USD","IE0002270589.USD","LU0256863902.USD","LU1244550577.SGD","LU1093756168.USD","LU1551013425.SGD","LU1718418525.SGD","BK4533","LU1934455277.USD","SG9999015978.USD","LU1934455194.USD","LU0211327993.USD","ABBV","LU0912757837.SGD","BK4534","SG9999015945.SGD","BK4559","LU2133065610.SGD","LU0689472784.USD","LABU","NUTX","LU0545039389.USD","LU0795875169.SGD","IE00BFTCPJ56.SGD","IE00BDGV0183.EUR","LU2089283258.USD","XBI","LU0211328371.USD","LU1732800096.USD","IE00B42XCP33.USD","BK4167","LU0965509101.SGD","LU1291159041.SGD","LU0965508806.USD","HCSG","LU1496350502.SGD","IE00BGHQF631.EUR","LU2089984988.USD","LU1061106388.HKD","SG9999003800.SGD","LU0128525929.USD","IE00B3PB1722.GBP","BK4196","LU1057294990.SGD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2586541912","title":"Repligen Corporation to Present at Evercore Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2586541912","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586541912?lang=en_us&edition=fundamental","pubTime":"2025-11-26 20:30","pubTimestamp":1764160200,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., Nov.  26, 2025  (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be particip","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/26/3195053/24603/en/Repligen-Corporation-to-Present-at-Evercore-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCSG","LU0029874061.USD","LABU","BK4585","LU0128526141.USD","BK4588","LU0757428866.USD","LU1815336091.USD","RGEN","BK4137","BK4581","BK4121","XLV","XBI"],"gpt_icon":0},{"id":"2586732254","title":"Sarepta Therapeutics (SRPT) Gets a Buy from Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2586732254","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586732254?lang=en_us&edition=fundamental","pubTime":"2025-11-26 20:28","pubTimestamp":1764160082,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Yanan Zhu maintained a Buy rating on Sarepta Therapeutics today and set a price target of $45.00. Zhu covers the Healthcare sec...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sarepta-therapeutics-srpt-gets-a-buy-from-wells-fargo-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sarepta-therapeutics-srpt-gets-a-buy-from-wells-fargo-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128525929.USD","LU0154236417.USD","LU0149725797.USD","LU0942090050.USD","IE00B2B36J28.USD","BK4139","LU0251142724.SGD","LU1363072403.SGD","LU0314106906.USD","LU1035773651.USD","LABU","LU1201861249.SGD","XBI","LU0128525689.USD","LU0708994859.HKD","LU0417517546.SGD","LU0310800379.SGD","XLV","LU0208291251.USD","LU0211327993.USD","BK4588","LU0971096721.USD","LU1668664300.SGD","IE00B19Z3581.USD","LU0868494617.USD","IE000M9KFDE8.USD","IE00BFTCPJ56.SGD","LU0029864427.USD","LU0320765489.SGD","LU0130517989.USD","LU0980610538.SGD","LU1069347547.HKD","LU2236285917.USD","LU0072461881.USD","LU0211328371.USD","SRPT","LU1074936037.SGD","LU0251131958.USD","LU0130102774.USD","LU0162691827.USD","LU2361044865.SGD","BK4581","BK4559","LU2361044949.HKD","IE00B19Z3B42.SGD","LU0052756011.USD","LU0648001328.SGD","IE0009355771.USD","LU0070302665.USD","BK4501"],"gpt_icon":0},{"id":"2586148251","title":"Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2586148251","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586148251?lang=en_us&edition=fundamental","pubTime":"2025-11-26 20:05","pubTimestamp":1764158700,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Nov.  26, 2025  (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its parti","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/26/3195029/0/en/Celcuity-To-Present-at-Upcoming-8th-Annual-Evercore-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LABU","HCSG","XLV","LU0128526141.USD","BK4588","BK4585","LU0029874061.USD","BK4581","BK4137"],"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":1,"totalSize":273,"code":"91000000","status":"200"}]}}